Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, someone said goodbye to about 5M shares at the BID.
Then about 3M at the ASK.
Either way, they are in someone else's hands now. I didn't have a bid in, asleep at the wheel.
https://ih.advfn.com/stock-market/USOTC/sohm-pk-SHMN/trades
hL shmn
Someone(s) getting out today. Some in/adding, share shuffle.
hL shmn
You certainly could be right, nothing should surprise us in the OTC that's for sure.
So your feeling then is that Aguilar, Night, Rushing, Bhat, and Tontat, have ulterior motives in their involvement with Sohm?
You feel like they are all in it to scam Investors?
You could certainly make that argument about Aguilar, as he stands to make millions from the sale to Sohm.
Bhat maybe too, as he owns a bunch of shares. (But only if the pps rises sharply)
___
But frankly neither of us have any credibility in the Biotech or Pharma world.
We're posting on an OTC message board, so what makes us authorities on any of this?
This is a Baby Pharma/Biotech at .0017. I see a sharp increase in Revenues in 2024...I see potential for them and us, imo.
hL shmn
Thanks for posting that video. Here's the link that shows the date of Jan 5, 2016. (7+ years)
https://www.youtube.com/channel/UCzvqpdRuUl0RhmnzQ1yLKrg/about
So do you feel like nothing has changed in the field of Targeted Gene Editing, CRISPR-Cas9, MRNA, and a Worldwide Pandemic seeking better ways to treat diseases than before?
Do you think the hiring of one of the Nations best IP Attorneys (Eric Furman) is irrelevant?
Is now not the right time to try to commercialize ABBIE kits?
Should all old patents and treatment strategies/theories be shelved because no one wanted them 7 years ago?
__
hL shmn
Hi Bob. Miro posted a pic of the Water Biz in Arizona still operational with Alkaline88 bottles in the pic...although it looked like they were hand packing a pallet of bottles that got dropped.
Also, Miro claims that WTER defaulted on a contract with HIRU, and hinted at ongoing potential legal actions/discussions aimed at them.
In the picture or not, WTER will forever be relevant to HIRU, until all matters get blown out in the wash.
Not that it matters...WTER didn't "sell" Alkaline 88.
It's "Licensing rights for 5 years to Clean Bottling," subject to various qualifiers, and disqualifiers.
https://www.otcmarkets.com/filing/html?id=16997834&guid=czd-kH2IptwfJth
"Pursuant to the License Agreement, the Clean Bottling owns the exclusive rights to manufacture, promote, advertise, distribute and sell the entire line of Alkaline 88 bottled water products...
"The term of the License Agreement will continue for five years, unless earlier terminated in accordance with the License Agreement."
Seems to me too, that WTER has to get delisted at some point from Nasdaq.
We also haven't heard if AWON will ever get a piece of the co-packing of Alkaline88, through Clean Bottling.
Read the full release herehttps://t.co/gdEslb90Ft pic.twitter.com/fuaWdi7tyF
— Alkaline88® (@Alkaline88) August 2, 2023
QB update this week, should be any day now. Also working on trying to sign a co-packing deal in the northeast with clean bottle after license agreement was announced on Friday with #WTER. $AWON
— AI_CPG (AWON) Pink Sheets (@A1Beverages) October 22, 2023
WTER 8K "Effective January 11, 2024, Frank Lazaran resigned as a director of the Company and Chairman of our board of directors.
Effective January 16, 2024, Frank Chessman resigned as the President and Chief Executive Officer of our company.
On the same date, we appointed David Guarino as our Interim Chief Executive Officer and President."
https://www.otcmarkets.com/filing/html?id=17212272&guid=czd-kH2IptwfJth
___
For some reason, I can't get to the IR section at the Alkaline88 website. Anyone else?
https://ir.thealkalinewaterco.com/company-information/management-team
https://ir.thealkalinewaterco.com/corporate-governance/board-of-directors
__
hL hiru
P.S: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173055966
Tony Tontat (continued):
Clinova: https://www.clinova.co.uk/team
Tony Tontat
Strategic Finance Advisor
https://www.clinova.co.uk/tony-tontat
"Tony Tontat is an advisor to the Clinova management team on strategic financing plans. He advises the company on long and short term financing.
Tony had been a NASDAQ company CFO and has served as the CFO for multiple private companies during and after their funding rounds ($15M to $250M IPO rounds). Tony has been a healthcare specialist for +20 years, working at the intersection of private companies plotting their path into the public markets.
Tony had been an investment banker at HSBC Investment Bank in their London, New York, and Paris offices. Tony holds an ALB in Economics from Harvard University."
____
https://www.benzinga.com/events/small-cap/company/kiromic-biopharma-inc/
Tony Tontat
CFO & COO
Kiromic Biopharma inc.
"Mr. Tontat has served as our Chief Operating Officer since August 2019, as our Chief Financial Officer since October 2019 and as a member of our board of directors since January 2020. Prior to joining us, Mr. Tontat worked as a business and financial consultant and Financial Analyst since November 2011 for Exuma Blue Advisors, LLC, where he worked with many private and public companies. He primarily helped these companies raise funds at various stages of life cycle. He worked in financial teams to raise funds for public companies like Sorrento Therapeutics, Inc. and NantKwest. Prior to this, he worked as an investment analyst at healthcare- specialist hedge funds in New York and also worked as investment banker at HSBC Investment Bank in their New York and Paris offices.
Mr. Tontat earned his BA in Economics from Harvard University."
EXUMA BLUE ADVISORS, LLC
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=ForwardRecord&SearchTerm=EXTREME%20WOOD%20WORKS%20OF&SearchNameOrder=EXUMABLUE%20P070000349380&ListNameOrder=EXUMA%203006800&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=flal-l17000159432-ea71fe9f-2051-4ed5-9535-06dcec7e1217&transactionId=l17000159432-b180ecdc-c5e4-4017-95e9-ab2f3325f51d&formatType=PDF
_____
hL shmn (Tony Tontat = Money Man IMO = Sohm Senior Financial Analyst)
Happy New Year!#SOHMINC$SHMN pic.twitter.com/kbTHsS4oLE
— SOHM, Inc. (@sohminc) January 1, 2024
And of course there's that opinion too. :)
hL shmn. Baby Pharma Biotech at .0021
There's a constant recurring theme to ABBIE communications:
"One of the key advantages of ABBIE is its design to provide enhanced precision. By fusing the Integrase enzyme with the cas9 protein, ABBIE allows for more accurate targeting of specific genomic sites, minimizing off-target effects. A high level of precision is crucial when introducing genetic modifications to crops, as it reduces the risk of unintended consequences and ensures the stability of the plant’s genome."
https://sohm.com/abbie-revolutionizing-agriculture-with-abbie-integrase-dcas9-fusion-protein-for-enhanced-genome-editing/
"As ABBIE depends on targeting genomic DNA like Zinc finger nucleases, AI will aid in increasing its specificity to reduce off target effects for safety."
https://sohm.com/gene-editing-therapy-and-artificial-intelligence/
"ABBIE differentiates from the CRISPR system by introducing DNA via a targeted integration mechanism and therefore does cause double stranded DNA breaks and importantly does not completely rely on cellular mechanisms of repair to generate an edit. In summary, the ABBIE system saves time and money by using an efficient mechanism of genetic delivery.
While genome editing is further researched for direct treatment and cure of human diseases, these systems are also being developed for agriculture, diagnostics and discovery of new drug targets.
SOHM envisions ABBIE in a system to quickly edit cells for drug screens. Cells can be engineered with ABBIE for expression of various drug targets such as receptors, kinases, cellular enzymes and other cellular proteins in normal and disease forms. These cells will better model in vivo disease mutations found in humans and can be used to find pharmacological targets and will be used in drug screens to identify lead compounds for a multitude of diseases.
The ABBIE screening system will be able to identify new therapeutic uses for new and existing drugs. "
https://sohm.com/abbie-in-advancing-drug-discovery/
"For example, ABBIE can be used to target and modify the cardiac conduction cells of the heart, which are responsible for generating and transmitting electrical signals that coordinate the heartbeat."
https://sohm.com/novel-gene-editing-tool-offers-hope/
"We are thrilled to introduce this game-changing technology to the world," said Dr. David Aguilar, Ph.D., SOHM’s COO. "Graphene nanoparticles have the potential to revolutionize genome editing, offering unprecedented precision and efficiency. We believe this breakthrough will have a profound impact on human health and open up new possibilities for scientific research as more gene therapies continue to pass FDA approvals."
https://www.globenewswire.com/news-release/2024/01/09/2806400/0/en/SOHM-Files-Provisional-Patent-on-ABBIE-s-Smart-Gene-Editing-That-Uses-Latest-Enzymes-and-Guide-RNA-to-Resolve-Off-Target-Gene-Editing-Limitations.html
"ABBIE falls in the domain of new genome editing systems that improve on the CRISPR-Cas9 yet retain the high targetability of the technology’s Cas9 proteins. For instance, ABBIE is poised to be able to edit genes of a large number of cell types at different stages of their life cycles, overcoming the limitations of current cell editing and cell engineering systems."
https://www.biomedwire.com/sohm-inc-s-shmn-new-gene-editing-technology-holds-potential-to-revolutionize-the-field-of-cardiology-with-superior-capabilities-over-other-gene-editing-systems/
___
More snipets could be pasted here on the above, but the recurring theme is evident.
I'm excited about it too myth, I know it's going to take time, but in my limited non-doctor/scientist/biologist self, it sounds very good, and Aguilar is doing a good job of explaining it in simple terms.
hL shmn Baby Pharma Biotech at .0021.
From Today's Blog/Tweet on ABBIE Revolutionizing Agriculture:
https://sohm.com/abbie-revolutionizing-agriculture-with-abbie-integrase-dcas9-fusion-protein-for-enhanced-genome-editing/
ABBIE: Revolutionizing Agriculture with ABBIE Integrase-dCas9 Fusion Protein for Enhanced Genome Editinghttps://t.co/9mXAF4JTi8 $SHMN
— SOHM, Inc. (@sohminc) January 29, 2024
LEVETIRACETAM tick tock February it's Jan 29th:
Let's hear about the "formalized contracts with Distributors" too please.
"After some initial technical/regulatory delays, it is expected that tablets bearing the SOHM label, LEVETIRACETAM, will arrive in the first week of February."
After a successful visit to Japan, our COO, Dr. David Aguilar is back and here are couple pictures of him working at Carlsbad facility with production in-charge.
— SOHM, Inc. (@sohminc) January 25, 2024
Secondly, we are glad to share that we are working with multiple companies for CDMO services and production at the… pic.twitter.com/Wj5qUGgpRe
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023
The whole thing sounds messy. I'd bet there's blanks to be filled in, imo.
I would have preferred for this debacle to be handled differently by everyone. It's quite a circus soap opera. Nevertheless, Good fortune to all shareholders, one way or another.
Respects Bob.
HL
That makes sense now why 3M sold at the ASK of .0019, when they weren't showing. I was thinking it was an AON order which happens too. Thanks for the info, and good fortune.
HL. Shmn
I was thinking most shares went off at the ASK today right?
Can't see time and sales right now.
Picasso paints down some days too, so it all evens out. :)
HL
It was "Filed and Recorded" yesterday with the Bibb County Georgia, Superior Ct Clerk. The Date and time stamp, and Instrument Number, is across the top of every one of the 7 pages.
I doubt the document is fake.
For whatever reason, HIRU is Tweeting about this today on their Twitter handle, which seems to indicate agreement with the filing. Maybe part of a new agreement, maybe it wasn't done before when it should have been? You got me, but the Filing shows that Bayern is the Secured Party, and those 6 pages of Equipment are Collateral. (See #4, on page One)
Pages 2-7, were originally a part of another document, as they are Pages 11-16 of the Original Document, which states "Equipment Lease" at the bottom of those pages. They were attached to the UCC Filing/Recording from yesterday.
https://www.gsccca.org/clerks/clerk-results?cid=11
--
HL
I did see something like that, also saw one about the "OTC verifying certain rumors."
Mining, logistics, water biz, Asian, ORV, Conference in SC, headed to CA, Vegas Marketing Show, Code Sharing, LOI/Definitive Agreement, UCC Filings, on and on...like playing ping pong on a Ferris Wheel. Making me dizzy. Gin n Tonics, have a good weekend.
hL
Hi Bob it's also about the "Secured Party" Bayern Industries:
https://www.otcmarkets.com/otcapi/company/financial-report/391157/content
https://www.superiorcourt.maricopa.gov/docket/CivilCourtCases/caseInfo.asp?caseNumber=CV2023-053912
On a separate note: I don't know why, but Frederick Bauman rang a bell. (The Attorney listed on the UCC Filing)
I was thinking he was the Attorney listed in the above linked complaint in Maricopa County, but that's William Kozub.
I wonder if HIRU is aware that Frederick is a "Prohibited Service Provider" for OTC Markets?
https://www.otcmarkets.com/learn/prohibited-service-providers
Next to his name is a link to an SEC Document from 2021...a Google Search has info too.
Not that it really matters, just thought it was interesting. HL hiru
That UCC Filing brings back some memories:
Like those "Case Palletizers." (12-13) (Not sure if they ever went operational?)
Also, the Distilled Water Equipment. (14-17) (Oh the humanity.)
Some said it never existed but there it is on the "Equipment List."
"800 Gallons per hour distillate output" ...as previously mentioned by Kathryn.
https://aqua-chem.com/vapor-compression-2/
But there it is, Itemized, with Manufacturer name, Make, and Serial Numbers.
https://www.otcmarkets.com/otcapi/company/financial-report/391157/content
(Edit) Some key equipment not on that list too, just off the top of my head the Multi-head bottle filler and Bottle blower from Denman. I suppose that stayed there, but Kathryn did say that some "key" equipment was coming from Denman when they "consolidated." Of course none of us will ever know what came from each of the several locations.
You probably saw where "you know who" spoke of a "hijacking."
___
hL hiru What a gut punch...carry on.
LEVETIRACETAM, if they do or don't, this is what we know:
"The Company confirms it has the necessary requisites to become a branded-generic manufacturer, including: scientific personnel, FDA-approved manufacturing facilities, as well as an appropriate marketing and sales strategy.
(Even though Levetiracetam will be made by Stallion Labs, parens are mine)
The Company aims to finish 2024 with a total of 20 branded generics in the market and manufacturing of its branded generic lineup. The Company anticipates deriving 50-55% of its revenues from the branded generic business division during the year 2024."
"It expects to earn several million from its business units, including ABBIE. This estimate is based on its internal actions, current opportunities, licensing deals, and kit adoption."
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706
__
So Several Million Total in 2024, could mean 3 Million, or 5 Million Total, or more maybe.
If it's 3 Million from everything, then 50% of that from Branded Generics would be 1.5 Million.
LEVETIRACETAM would only be one of those 20 Branded Generics they "aim" to be selling.
That infers to me that while LEVETIRACETAM could easily sell as much as they generated in all of 2023...it isn't expected to be a "huge Shipment" yet, imo. (Unless they surprise us.)
LEVETIRACETAM is only one piece of the puzzle, but an important one, as it could grow with the right contract, and could be one key Branded-Generic that helps them to be self-sufficient without needing to manufacture, or dilute the stock.
"Formalizing Contracts and Distributors on Levetiracetam."
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023
Officer(s) Removed, Kathryn Gavin Consultant:
https://www.otcmarkets.com/stock/HIRU/profile
🚨 $HIRU
— OTC Updates (@OtcUpdates) January 23, 2024
💰0.0009
Pink Current, AS: 3.9B, OS: 2.9B, US: 1.9B
Officer(s) Removed:
🔴Kathryn Gavin, Consultant
https://t.co/IFke88mBUL
Thanks for checking, and letting us know.
Terrible Flooding from Yesterday and Today.
Maybe they will Tweet out that the SD facility is ok.
Feeling for all those affected more importantly.
Looks like we're on the "Orange Line" of the Trolley System, 25th and Commercial Station. (2501 Commercial St)
https://maps.app.goo.gl/F6vcfkQWnZ1nab6AA
https://www.sdmts.com/transit-services/trolley
A powerful storm front stretching for hundreds of miles dumped heavy rain on much of California on Monday, causing rare widespread flooding in parts of the state.
— CBS Mornings (@CBSMornings) January 23, 2024
Hundreds of people had to be rescued from their homes in San Diego, officials said. https://t.co/dSUbmUPHQV pic.twitter.com/twSRbC4NeV
Thanks for the info CT. Hl. Shmn
If Night and Aguilar don't respond to your goading:
...let's remind them this way:
(11.21.23)
"The company is excited to announce the opening of a new facility in Carlsbad to meet the growing demand for its products. This facility will handle the orders that SOHM has received and expects to receive in the near future, while its main facility in downtown San Diego undergoes renovation to become fully operational. SOHM aims to complete the engineering batches produced in the San Diego facility by Q1 2024. This expansion is part of the company’s strategic plan to enhance its production capacity and efficiency.
As of this press release, the facility is near-final. Full cGMP manufacturing capacity is expected to be completed by December 2023."
“I am very proud to launch this facility with our SOHM team members. This Carlsbad facility is conveniently located right at the mid-way between two importing commercial hubs: Los Angeles and San Diego. Our location on major land shipping routes will play an important role in maintaining our competitive pricing edge in material sourcing and final products to our clients. Many people do not know this, but Carlsbad is also the home to many biotech and pharma companies who routinely rely on CDMO operators like SOHM for their bio-manufacturing needs,” says Dr. David Aguilar, COO.
Dr. Aguilar continues, “In 12 months, our Carlsbad facility will be expecting to manufacture 70% Rx and 30% OTC (over-the-counter) products. This facility will be able to meet all of our short-term SOHM brand Rx topical and OTC product manufacturing with 100% allocated to manufacture for CDMO clients whose orders are now arriving for year-end-2023.”
Key Milestone:
-- Engineering batch of topical branded generic completed within this financial year/2023
-- Initial released batch to client by 1Q 2024
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-New-CDMO-GMP-Manufacturing-Facility-in-Carlsbad-California?id=422243
(12.5.23)
"The Company confirms it has the necessary requisites to become a branded-generic manufacturer, including: scientific personnel, FDA-approved manufacturing facilities, as well as an appropriate marketing and sales strategy.
The Company already has orders for its CDMO services and will launch two units to perform the manufacturing for these CDMO clients by 4Q-2023 and into 2024.
The Company will be manufacturing its ABBIE gene-editing kit at its manufacturing facilities in San Diego and Carlsbad. "
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706
(1.1.24)
"We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook."
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023
Agree Aguilar and Gallegos go way back:
https://www.linkedin.com/in/david-aguilar-ph-d-51b8003a/
_______
...I also thought the same thing about Gallegos "out of retirement" too.
CT Question: Are you feeling like the "Renovations" at the SD Facility are because of the "storage protocols?"
Possibly refrigeration, or climate control? (For the Levetiracetam, and anything else that gets made/stored in that facility in the future?)
Or better security, lock-downs, camera surveillance, etc?
hL
SHMN Baby Pharma/Biotech. .0016 2.7M Market Cap.
Have a good weekend everyone. Gin n Tonics. hL shmn
"The Company confirms it has the necessary requisites to become a branded-generic manufacturer, including: scientific personnel, FDA-approved manufacturing facilities, as well as an appropriate marketing and sales strategy.
The Company aims to finish 2024 with a total of 20 branded generics in the market and manufacturing of its branded generic lineup. The Company anticipates deriving 50-55% of its revenues from the branded generic business division during the year 2024."
"The Company is expanding its revenue growth in various pharmaceutical and biotech sectors. It has set a 2024 target and is taking steps to achieve it. It wants to excel in cell therapy and gene editing. It expects to earn several million from its business units, including ABBIE. This estimate is based on its internal actions, current opportunities, licensing deals, and kit adoption. This was announced by Mr. Baron Night, CEO and president, and Dr. David Aguilar, COO."
https://www.globenewswire.com/news-release/2023/12/05/2791056/0/en/SOHM-Announces-Business-Outlook-for-2024.html
hL shmn
Alfred Gallegos, SOHM Inc, Full Time, Research Scientist, University of Arizona:
https://www.linkedin.com/in/alfred-gallegos-453367b3/
35 Years at University of Arizona
(39) Publications:
https://www.researchgate.net/profile/Alfred-Gallegos
https://www.researchgate.net/publication/305666139_Abstract_2749_A_novel_small_molecule_inhibitor_targets_the_DNA_double_strand_break_repair_protein_Ku7080
Virtual tour of our lab at University of Arizona, Center for Innovation. https://t.co/IAVR2b0oal via @YouTube $SHMN
— SOHM, Inc. (@sohminc) October 13, 2023
They never said they would manufacture LEVETIRACETAM.
That is the context of this post stream, with that particular Generic RX drug.
They have an exclusive deal with Stallion Labs in India (the manufacturer) to market that specific Generic Rx drug in the U.S. under the Sohm Label and NDC numbers.
_______
The "Manufacturing" facilities are not yet producing topicals to my knowledge.
The Manufacturing facility doesn't have to be "Manufacturing" to "Sell" (Private Label) drugs, made by someone else.
They haven't spent their time and money on the Facilities to collect dust.
They haven't brought all these people in for nothing.
It takes time and patience. If you don't think it will happen, then make the tough decisions for yourself, right? Respectfully.
hL shmn
Very informative article, thank you. hl shmn
Thanks for that link, here's the one for AACR:
https://www.aacr.org/professionals/meetings/meetings-and-workshops-calendar/?meetingtype=conferences
"ABBIE development will be presented at the following scientific conferences:
Apr 2024: American Association of Cancer Research, AACR 2024, in San Diego, California
May 2024: SynbioBeta 2024 in San Jose, California"
https://www.globenewswire.com/news-release/2023/09/26/2749662/0/en/SOHM-Announces-Its-Acquisition-of-ABBIE-a-World-Class-Gene-Editing-Platform-Which-Can-Deliver-Genetic-Payloads-Using-Non-Viral-Vectors.html
"Interim scientific results from R&D will be available during SOHM’s participation at:
April 2024: American Association of Cancer Research 2024 in San Diego, CA
May 2024: SynbioBeta 2024 in San Jose, CA"
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706
__
hL shmn
Fair answer, and thanks for the link. hl shmn
"LEVETIRACETAM Contracts being formalized with Distributors."
What would you estimate are the margins for this particular Generic RX?
tia. hL shmn
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023
Thanks Bob. That's puzzling, because they didn't list HIRU or AZ Custom as Defendants...only Kathryn. Other companies (LLC's) are listed as Defendant's...odd, imo.
HL
New Complaint, 12.27.23 Maricopa County:
Mirna Bernal Ayon
Plaintiff
Arnulfo Bernal Ayon
Plaintiff
Elvira Carolina Ayon Pedroza
Plaintiff
A B S Investing L L C
Defendant
S R Liquidators L L C
Defendant
A Q 1 Management
Defendant
Antonio Quintanilla
Defendant
Theresa Quintanilla
Defendant
Kathryn Gavin
Defendant
https://www.superiorcourt.maricopa.gov/docket/CivilCourtCases/caseInfo.asp?caseNumber=CV2023-020218
__
No idea what it's about, but SR Liquidators LLC is showing to have the same address as HIRU in Arizona.
https://opencorporates.com/companies/us_az/L19664458
______
Bayern Case still ongoing, but no idea about progress. Last entry 12/8/23.
https://www.superiorcourt.maricopa.gov/docket/CivilCourtCases/caseInfo.asp?caseNumber=CV2023-053912
____
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173024967
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173025005
hL
"Hiru blew itself up." Great way to put it, I thought that when you wrote it, and it still rings in my ears.
"Info you’re reading is before Hiru blew itself up. It’s a total new situation with less value than where it’s trading. You should do some serious research regarding the current circumstances of Hiru. It might go up but it won’t be based off the filing you’re talking about."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173568216
I had a positive outlook here. Disappointed but can't change it. The August 2023 Alkaline 88 letter...Gut punch, in hindsight.
Still watching here from the bleachers. Respects QT. hL
I'm still bidding for more here in the teens. I don't know where we will settle, but I don't think it will matter where we buy in the teens as even the flippers are looking at an easy double if they hold, imo. (which they won't)
I got some .0016's yesterday. Looks to me like most shares are being held until we break and pass .0019.
On the road today, good fortune and do your own DD.
I'm not the greatest trader, far from it. Keep making strides Sohm.
hL shmn
Nice close, volume. .0019 +26.67%
hl shmn
Yup.
SOHM Inc. (SHMN) Announces Filing of Provisional Patent for ABBIE Smart Gene Editing Technologyhttps://t.co/uc8PdOkAMN
— SOHM, Inc. (@sohminc) January 9, 2024
New provisional patent filed is additional patent.$SHMN
Yes about 8.5 months ago. You've been following my posts about Levetiracetam, and others too. It took awhile. The Company has communicated that it has arrived and is now on their website. Just last week we heard they were "formalizing Contracts and Distributors."
It's here, it's verifiable in 4 different dosages.
It's on the FDA listings.
The label shows Stalion as the manufacturer.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173329546
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a688786-879b-4e27-a46a-5c86bbfa1292
___
It's here. Sales are forthcoming, imo.
https://sohm.com/rx-generic/
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023